13F HOLDINGS REPORT
OUP Management Co., LLC
Quarter ended Q1 2023 · Filed February 2, 2023 · Accession 0000950123-23-000672
Total Value
$61.3M
Positions
14
Other Managers
0
Confidential Omitted
No
Holdings (14)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Aerovate Therapeutics Inc. | 008064107 | 603,762 | $17.7M | 28.88% |
| 2 | Centessa Pharmaceuticals plc | CNTA | 2,937,615 | $9.1M | 14.87% |
| 3 | PMV Pharmaceuticals, Inc. | PMVP | 989,232 | $8.6M | 14.05% |
| 4 | DICE Therapeutics Inc. | 23345J104 | 268,346 | $8.4M | 13.67% |
| 5 | ionQ, Inc. | IONQ-WT | 1,177,597 | $4.1M | 6.63% |
| 6 | Cyteir Therapeutics, Inc. | 23284P103 | 2,459,572 | $4.1M | 6.63% |
| 7 | Vor Biopharma Inc. | VOR | 374,714 | $2.5M | 4.07% |
| 8 | Prime Medicine, Inc. | PRME | 121,255 | $2.3M | 3.68% |
| 9 | Graphite Bio | 38870X104 | 406,308 | $1.3M | 2.20% |
| 10 | Precision BioSciences, Inc. | DTIL | 1,123,913 | $1.3M | 2.18% |
| 11 | Selecta Biosciences, Inc. | 816212104 | 862,543 | $974,674 | 1.59% |
| 12 | eFFECTOR Therapeutics, Inc. | 28202V108 | 1,025,697 | $438,588 | 0.72% |
| 13 | Spero Therapeutics, Inc. | SPRO | 249,070 | $430,891 | 0.70% |
| 14 | Homology Medicines, Inc. | 438083107 | 64,000 | $80,640 | 0.13% |